Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tea Drinking Significantly Reduces Risk of Stroke

By LabMedica International staff writers
Posted on 04 Mar 2009
A recently published study reviewed the experimental evidence linking tea drinking and stroke and concluded that drinking at least three cups of tea a day significantly reduces stroke risk.

Investigators from the University of California, Los Angeles (UCLA; USA) searched the Internet for all studies on stroke and tea consumption in humans with original data, including estimation or measurement of tea consumption and outcomes of fatal or nonfatal stroke. More...
Data from nine studies involving 4,378 strokes among 194,965 individuals were pooled.

Results published in the February 19, 2009, online edition of Stroke, a Journal of the American Heart Association, revealed that regardless of their country of origin, individuals consuming at least three cups of tea per day had a 21% lower risk of stroke than those consuming less than one cup per day. The tea could be black or green as long it was from the classical tea plant Camellia sinensis and not an herbal tea.

So far, researchers have failed to identify the compounds in tea responsible for the stroke-reducing effect. Speculation points to the antioxidant epigallocatechin gallate (EGCG) or the amino acid theanine. Theanine is especially interesting, as it is related to glutamine and can cross the blood-brain barrier. Since it can enter the brain, theanine has psychoactive properties. Theanine has been shown to reduce mental and physical stress and produce feelings of relaxation.

"What we saw was that there was a consistency of effect of appreciable magnitude,” said first author Dr. Lenore Arab, professor of biological chemistry at the University of California, Los Angeles. "By drinking three cups of tea a day, the risk of a stroke was reduced by 21%. It did not matter if it was green or black tea. That is why these findings are so exciting. If we can find a way to prevent the stroke, or prevent the damage, that is simple and not toxic, that would be a great advance. We do know that theanine is nearly 100% absorbed. It gets across the blood-brain barrier and it looks a lot like a molecule that is very similar to glutamate, and glutamate release is associated with stroke. It could be that theanine and glutamate compete for the glutamate receptor in the brain.”

Related Links:
University of California, Los Angeles




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.